首页>
外国专利>
B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME
B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME
展开▼
机译:B细胞耗竭剂,如抗CD20抗体或其片段,用于治疗慢性疲劳综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to an anti-CD20 antibody or a CD20-binding antibody fragment thereof for the treatment of chronic fatigue syndrome and myalgic encephalomyelitis. In particular, the present invention relates to the use of anti-CD20 monoclonal antibodies or fragments thereof which are preferably humanized for the treatment of the chronic fatigue syndrome/myalgic encephalomyelitis in a subject afflicted with said disease.
展开▼